David William Will

This inventor holds 40 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh, Sanofi. Active years: 1998-2014.

USPTO Granted Patents = 40 (Patent Applications = 4)

% Patents Active = 30.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 388(Granted Patents)

Location History:

Eschborn, DE (1998)
Schwalbach, DE (2001 - 2004)
Kriftel, DE (2002 - 2012)
Frankfurt-am-Main, DE (2011 - 2014)

Company Filing History:

17 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

5 out of 330

Aventis Pharma Deutschland, Gmbh

Hoechst Aktiengesellschaft

patents

8. 5 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2014

Loading Chart...

Areas of Expertise:

Heteroaryl Amides

Pyridazinone Derivatives

Nucleic Acid Derivatives

Factor Xa Inhibitors

Polyamide Derivatives

Imidazole Derivatives

Sulfonamide Derivatives

Guanidine Derivatives

Acylguanidines

Antisense Nucleotides

Cell Adhesion Inhibitors

Pharmaceutical Compositions

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8642620 - Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals (2014-02-04),

2. 8518976 - Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals (2013-08-27),

3. 8399476 - Imidazo[1,2-a]pyridines and their use as pharmaceuticals (2013-03-19),

4. 8304438 - Heteroarylacrylamides and their use as pharmaceuticals (2012-11-06),

5. 8299102 - Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals (2012-10-30),

6. 8268560 - Polymide nucleic acid derivatives, and agents and processes for preparing them (2012-09-18),

7. 8188291 - Heteroaryl-substituted carboxamides and their use as pharmaceuticals (2012-05-29),

8. 8168665 - Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals (2012-05-01),

9. 8080569 - Imidazo[2,1-b]thiazoles and their use as pharmaceuticals (2011-12-20),

10. 8044050 - Imidazo[1,2-a]azines and their use as pharmaceuticals (2011-10-25),

11. 7968546 - Pyridazinone kinase inhibitors (2011-06-28),

12. 7910606 - Pyrazole-derivatives as factor Xa inhibitors (2011-03-22),

13. 7897346 - Polyamide nucleic acid derivatives and agents, and processes for preparing them (2011-03-01),

14. 7754713 - 4-benzimidazol-2-ylpyridazin-3-one derivatives (2010-07-13),

15. 7727989 - 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments (2010-06-01),

Title: Inventor David William Will

Introduction: David William Will is a renowned inventor based in Kriftel, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: David William Will holds several patents in the fields of renewable energy, sustainable technology, and advanced materials.

Career Highlights: Throughout his career, David William Will has been instrumental in developing innovative solutions that have revolutionized the way we approach environmental challenges and technological advancements.

Collaborations: David William Will has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market successfully.

Conclusion: David William Will's dedication to innovation and his passion for creating a sustainable future have solidified his reputation as a visionary inventor in the global landscape.